Table 1

 Underlying cardiac disease in 153 episodes of infective endocarditis during two time periods

<1990⩾1990
*Other non-prosthetic lesion; †one Fallot with pulmonary atresia; ‡regular Fallot; §Fallot repair with pacemaker; ¶including four tetralogies of Fallot.
ASD, atrial septal defect; AVSD, atrioventricular septal defect; CHD, congenital heart disease; MVP, mitral valve prolapse; PDA, patent ductus arteriosus; PM, pacemaker; SP, systemic-to-pulmonary; VSD, ventricular septal defect.
Previous correction
VSD patch5 (23.8%)1 (5.5%)
VSD patch + prosthetic02 (11.1%)
VSD patch + other*4 (19.0%)1 (5.5%)
Rastelli conduit (1 PM)1 (4.8%)5 (27.8)†
Tetralogy of Fallot‡ (1 PM)4 (19.0%)1 (5.5)§
Coarctectomy1 (4.8%)1 (5.5%)
Senning01 (5.5%)
Switch operation1 (4.8%)0
ASD closure + other1 (4.8%)2 (11.1%)
Prosthetic valve3 (14.3%)4 (22.2%)
Pacemaker1 (4.8%)0
Total2118
Previous palliation
SP shunt12 (80.0%)¶16 (80.0%)
Banding + SP shunt1 (6.7%)0
Aortic valvulotomy01 (5.0%)
Aortic conduit1 (6.7%)1 (5.0%)
Banding + coarctectomy02 (10.0%)
Coarctectomy1 (6.7%)0
Total1520
Non-operated
VSD7 (15.6%)11 (32.4%)
VSD + left heart anomaly3 (6.7%)1 (2.9%)
VSD + right heart anomaly1 (2.2%)0
PDA1 (2.2%)0
PDA + other1 (2.2%)1 (2.9%)
AVSD2 (4.4%)0
Tetralogy of Fallot2 (4.4%)0
MVP3 (6.7%)1 (2.9%)
Mitral regurgitation3 (6.7%)5 (14.7%)
Bicuspid aortic valve1 (2.2%)3 (8.8%)
Aortic valve stenosis1 (2.2%)0
Mitroaortic anomalies01 (2.9%)
Pulmonary valve stenosis1 (2.2%)0
ASD + MVP1 (2.2%)0
Aortic coarctation1 (2.2%)0
Complex CHD4 (8.9%)3 (8.8%)
Undetermined13 (28.9%)8 (23.5%)
Total4534